The Role of Oxidative Stress and Cellular Senescence in the Pathogenesis of Metabolic Associated Fatty Liver Disease and Related Hepatocellular Carcinoma
Authors:
- Nikolaos-Andreas AnastasopoulosNikolaos-Andreas Anastasopoulos
- Antonia V. CharchantiACAntonia V. Charchanti
- Alexandra BarboutiABAlexandra Barbouti
- Eleftheria M. MastoridouEMEleftheria M. Mastoridou
- Anna C. GoussiaAGAnna C. Goussia
- Anastasia D. KarampaAKAnastasia D. Karampa
- Dimitrios ChristodoulouDCDimitrios Christodoulou
- Georgios K. GlantzounisGGGeorgios K. Glantzounis
Open Access
- 14 June 2023
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 12 (6) , 1269
Abstract
Hepatocellular carcinoma (HCC) represents a worryingly increasing cause of malignancy-related mortality, while Metabolic Associated Fatty Liver Disease (MAFLD) is going to become its most common cause in the next decade. Understanding the complex underlying pathophysiology of MAFLD-related HCC can provide opportunities for successful targeted therapies. Of particular interest in this sequela of hepatopathology is cellular senescence, a complex process characterised by cellular cycle arrest initiated by a variety of endogenous and exogenous cell stressors. A key biological process in establishing and maintaining senescence is oxidative stress, which is present in multiple cellular compartments of steatotic hepatocytes. Oxidative stress-induced cellular senescence can change hepatocyte function and metabolism, and alter, in a paracrine manner, the hepatic microenvironment, enabling disease progression from simple steatosis to inflammation and fibrosis, as well as HCC. The duration of senescence and the cell types it affects can tilt the scale from a tumour-protective self-restricting phenotype to the creator of an oncogenic hepatic milieu. A deeper understanding of the mechanism of the disease can guide the selection of the most appropriate senotherapeutic agent, as well as the optimal timing and cell type targeting for effectively combating HCC.Keywords
This publication has 115 references indexed in Scilit:
- Leprdb/db Mice with Senescence Marker Protein-30 Knockout (Leprdb/dbSmp30Y/−) Exhibit Increases in Small Dense-LDL and Severe Fatty Liver Despite Being Fed a Standard DietPLOS ONE, 2013
- Cellular senescence and the senescent secretory phenotype: therapeutic opportunitiesJournal of Clinical Investigation, 2013
- p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and miceJournal of Hepatology, 2012
- Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in MiceGastroenterology, 2012
- Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in miceHepatology, 2012
- Feedback between p21 and reactive oxygen production is necessary for cell senescenceMolecular Systems Biology, 2010
- Senescence of Activated Stellate Cells Limits Liver FibrosisCell, 2008
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasNature, 2007
- A DNA damage checkpoint response in telomere-initiated senescenceNature, 2003
- Aging: A Theory Based on Free Radical and Radiation ChemistryJournal of Gerontology, 1956